Evidence map›Paper›PMID 21551225›Full record

ArticleMolecular cancer research : MCR2011

NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.

Kathleen A Wilson, Sierra A Colavito, Vincent Schulz, Patricia Heffernan Wakefield, William Sessa, David Tuck, David F Stern

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Contributions of Rad9 to tumorigenesis.Journal of cellular biochemistry · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kathleen A WilsonYale University, 333 Cedar Street, P.O. Box 208023, New Haven, CT 06520, USA.
Sierra A Colavito
Vincent Schulz
Patricia Heffernan Wakefield
William Sessa
David Tuck
David F Stern
Yale University · US

Funding

PROTEIN KINASES IN YEAST DNA CHECKPOINT PATHWAYSR01CA082257 · NCI · YALE UNIVERSITY · PI STERN, DAVID F · 1999 to 2009
$2.3M
NCI NIH HHS R01 CA082257NCI NIH HHS R01CA82257
6 · The paper itself

Abstract

NFBD1/MDC1 is involved in DNA damage checkpoint signaling and DNA repair. NFBD1 binds to the chromatin component γH2AX at sites of DNA damage, causing amplification of ataxia telangiectasia-mutated gene (ATM) pathway signaling and recruitment of DNA repair factors. Residues 508-995 of NFBD1 possess transactivation activity, suggesting a possible role of NFBD1 in transcription. Furthermore, NFBD1 influences p53-mediated transcription in response to adriamycin. We sought to determine the role of NFBD1 in ionizing radiation (IR)-responsive transcription and if NFBD1 influences transcription independently of p53. Using microarray analysis, we identified genes altered upon NFBD1 knockdown. Surprisingly, most NFBD1 regulated genes are regulated in both the absence and presence of IR, thus pointing toward a novel function for NFBD1 outside of the DNA damage response. Furthermore, NFBD1 knockdown regulated genes mostly independent of p53 knockdown. These genes are involved in pathways including focal adhesion signaling, carbohydrate metabolism, and insulin signaling. We found that CAV1 and CAV2 mRNA and protein levels are reduced by both NFBD1 knockdown and knockout independently of IR and p53. NFBD1-depleted cells exhibit some similar phenotypes to Cav1-depleted cells. Furthermore, like Cav1-depletion, NFBD1 shRNA increases Erk phosphorylation. Thus, Cav1 could act as a mediator of the DNA-damage independent effects of NFBD1 in mitogenic signaling.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAtaxia Telangiectasia Mutated ProteinsCaveolin 1Caveolin 2Cell AdhesionCell Cycle ProteinsCell Line, TumorCells, CulturedChromatinDNA-Binding ProteinsDNA DamageDNA RepairFibroblastsGene Knockdown TechniquesHistonesAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseCAV1 protein, humanCAV2 protein, humanCaveolin 1Caveolin 2Cell Cycle ProteinsChromatinDNA-Binding ProteinsH2AX protein, humanHistonesMDC1 protein, humanNuclear ProteinsProtein Serine-Threonine KinasesRNA, MessengerTrans-ActivatorsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID21551225
PMCPMC3901581
OpenAlexW2114073410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.